Standalone Unaudited Financial Results for the quarter ended June 30, 2026.

LOoOTUS Lotus Eye Hospital And Institute Limited 0 CIN No. : L851107TZ1997PLC007783 e o 770/12, Avinashi Road, Civil Aerodrome Post, Coimbatore - 641 014. Tel : 0422 - 4229900, 4229999 Al PA R.S.PURAM 1558, East Periasamy Road, Near Chinthamani, 86/1, Site No.2, TRM Avenue, Sathy Road, North Coimbatore, R.S.Puram, Coimbatore - 641 002. Saravanamipatti, Coimbatore - 641 035. Ph: 0422 - 2210021 Ph : 0422 - 4239900, 4239999 E-mail : info@lotuseye.org Website : www.lotuseye.org August 10, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Mumbai — 400 001 Bandra (East), Mumbai — 400 051 Scrip Code: 532998 Scrip Code: LOTUSEYE Sir/Madam, Sub: Outcome of the Board Meeting Pursuant to Regulation 30, 33 and other applicable provisions, if any, of the SEBI (LODR) Regulations, 2015, we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e., Monday, August 10, 2026, has approved the Standalone Unaudited Financial Results of the Company for the quarter ended June 30, 2026 along with the Limited Review Report issued by the Statutory Auditors of the Company. The Board Meeting commenced at 04:50 PM and ended at 05:30 PM. This is for your information and records. Thanking You For Lotus Eye Hospital and Institute Limited Prathish S Company Secretary & Compliance Officer 'SALEM : 86, Brindhavan Road, Fairlands, Salem - 636 016. Ph :0 427 - 4219900, 4219999 TIRUPUR : 415, Kamaraj Road, Santhai Pettai Bus Stop, Thennampalayam, Palladam Road, Tiruppur - 641 604, Ph : 0421 - 4346060, 4219999 METTUPPALAYAM : No. 28, Coimbatore Main Rd, Opp.Bus Stand, Mettupalayam - 634 301. Ph ; 04254 - 223223, 224224 KOCHI : 533/33A-33F, Tejas Tower, SA Road, Kadavanthara, Kochi, Kerala - 682 020. Ph. : 0484 - 2322333, 2322444 KOCHI : 2294, Kurisingal House, Mulanthuruty Post, Kochi, Kerala - 682 314, Ph. : 0484 - 2743191, 2743121 KARUR : Door No.28,28/2, Sengunthapuram Main Road, Karur - 639002. Ph : 04324 459900, 74485 14851 GOBICHETTIPALAYAM : 4/1240, Opp to Nanjappa Nagar, Kullampalayam Pirivu, Erode Main Road, Gobichettipalayam, Erode - 638476. Ph : 04285 222899 LoOoTUS /\ Lotus Eye Hospital and Institute Limited @ CIN: L85110TZ1997PLC007783 \,\/ Registered office: 770/12, Avinashi road, Aerodrome post, Coimbatore 641 014 i Phone no: 0422-4229900, Fax: 04224229933, E-mail: companysecretary@lotuseye.org, Website: www.lotuseye.org Statement of Un-audited Financial Results for the Quarter ended June 30, 2026 (Rs. in lakhs) . uarter Ended Year Ended Nei Particulars June 30,2026 March 31,2026 | June 30,2025 | March 31,2026 (Unaudited) (Audited) (Unaudited) (Audited) Income: L [Revenue from operations 1,705.71 1,360.92 135169 537141 1. |Other income 21.08 4822 117.62 1IL | Total income (1+11) 1,726.79 1,409.14 5,489.03 V. |Expenses; (&) Cost of materials consumed 26322 19352 23592 852.09 (b) Purchase of stock-in-trade 254.02 21751 184.20 813.52 (c) Changes in inventories (28.08) 158 (1.46) (152) (d) Service expenses 324.82 280.70 26120 1,092.60 (e) Employee benefit expense 364.89 325.88 284.38/ 1217.33 (f) Finance costs 50.65 3313 1176 85.92 (8) Depreciation and amortization expense 163.54 110.27, 81.89 374.94 (h) Other expenses 23238 293.89 239.85 1,059.10 Total expenses (V) 1,625.44 1,456.48 1,297.74 5,493.98 V. | Profit/(loss) before exceptional items and tax (11I-1V) 101.35 (47.34) 7271 (4.95) V1. |Exceptional items (0.33) (0.79) 027 (041) VIL| Profit/(loss) before tax (V+VI) 101.02 (48.13) 72.98 < (5.36) VIIL |T ax expenses (a) Current tax - (7.24) 1431 0.41 (b) Deferred tax 39.65 (8.94) 419 (13.81) Total tax expense (VIII) 39.65 (16.18) 1850 (13.40) IX. | Net profit/(loss) for the period (VII-VIlI) 61.37 (31.95) 54.48 8.04 X. |Other comprehensive income, net of income tax A. Items that will not be reclassified to profit or loss - Remeasurement of post-employment defined benefit plans 2.00 16.89 (3.00) 7.89 - Income tax on the above item (120 (4.70) 083 (2:20) B. Items that will be reclassified to profit or loss - - - - Total other comprehensive income, net of income tax (X) 080 1219 (217) 5.69 X1, | Total comprehensive income for the period (IX +X) 62.17 (19.76) 5231 13.73 XIl. |Paid-up equity share capital (face value of Rs. 10/- each) 2,079.63 2,079.63 2,079.63 2,079.63 XL Earning per equity share: (of Rs. 10/-) (Not annualised except for the year ended March): (1) Basic (in Rs.) (0.15) 0.26 0.04 (2) Diluted (in Rs.) (0.15) 0.26 0.04 For Lotus & Institute Limit ' an =4 < Ms. 87 SANGEETHA ging Directop/~ DIN : 01859252 Notes: The above unaudited financial results have been reviewed by the Audit committee and the same has been approved by the Board of Directors at their meeting held on 10th August, 2026. The statutory auditors have conducted a limited review of the financial results. Exceptional items represent the profit/(loss) on sale of property,plant & equipment. 3. The Company does not have any Subsidiary/ Associate/ Joint Venture and hence preparation of Consolidated Financial Results for the quarter ended June 30, 2026 and year ended March 31, 2026 are not applicable. The Company operates in a single segment ie. "Eye Care related sales and services” and does not have any| additional disclosures to be made under Ind AS 108 - Operating Segments. The figures for the quarter ended March 31, 2026 are the balancing figures between the audited figures in respect of| the full financial year and the year-to-date figures upto third quarter of the respective financial years, which were subject to limited review by the Statutory auditors. Figures of the previous period/ year have been regrouped / rearranged wherever necessary to conform to the current period / year presentation. Coimbatore, August 10, 2026. For Lotus Eye Hospital & Insfitute Limited . S SANGEETHA y/ naging Dirgefor - DIN 01859252 ANBARASU & JALAPATHI CHARTERED ACCOUNTANTS INDIA The Board of Directors, Lotus Eye Hospital and Institute Limited, Coimbatore. Limited review report for the Quarter ended June 30, 2026 We have reviewed the accompanying statement of unaudited financial results of Lotus Eye Hospital and Institute Limited (“the Company”) for the quarter ended June 30, 2026, being submitted by the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended. This statement which is the responsibility of the Company’s management and approved by the Board of Directors at their meeting on August 10, 2026, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 “Interim Financial Reporting” (“Ind AS 34”), prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally acceptedi n India. Our responsibilityi s to issue a report on these financial statements based on our review. We conducted our review in accordance with the Standard on Review Engagement (SRE) 2410, ‘Review of Interim Financial Information Performed by the Independent Auditor of the Entity’ issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limited primarily to inquiries of company personnel and analytical procedures applied to financial data and thus provide less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. Based on our review conducted as stated above, nothing has come to our attention that causes us lo believe that the accompanying statement of unaudited financial results prepared in accordance with the aforesaid Indian Accounting Standards and other recognized accounting practices and policies, have not disclosed the information required to be d [Showing first 8,000 characters — download PDF for full document]